| | | | | | | |
 | MODERNA, INC. | -4.97% | -1.20% | -46.35% | -17.91% | 502.88% | 57 031 |
 | LONZA GROUP AG | 2.96% | 0.38% | -27.84% | -3.21% | 77.00% | 40 761 |
| IQVIA HOLDINGS INC. | 0.04% | -3.30% | -28.46% | -14.75% | 50.99% | 38 185 |
| SEAGEN INC. | -2.10% | 2.96% | -9.68% | -10.10% | 116.90% | 26 255 |
| ICON PUBLIC LIMITED COMPANY | 0.86% | 2.42% | -30.22% | -6.46% | 57.42% | 17 418 |
| ALNYLAM PHARMACEUTICALS, INC. | 2.25% | 6.62% | -22.00% | -5.59% | 100.84% | 15 628 |
 | CELLTRION, INC. | 2.84% | 2.84% | -26.77% | -45.22% | -15.74% | 15 388 |
| BIO-TECHNE CORPORATION | -0.02% | -0.39% | -29.19% | -10.40% | 85.54% | 14 377 |
 | PHARMARON BEIJING CO., LTD. | 3.00% | 1.89% | -19.46% | -37.09% | 231.72% | 12 310 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 0.38% | -1.34% | -38.26% | -28.79% | 80.72% | 11 775 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 4.99% | 3.72% | -30.35% | -45.56% | 96.35% | 10 526 |
| QIAGEN N.V. | 1.84% | 0.41% | -18.55% | -6.85% | 19.10% | 10 110 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.69% | 0.73% | 3.06% | 87.87% | 130.19% | 10 021 |
| UNITED THERAPEUTICS CORPORATION | 1.08% | 2.67% | -12.84% | -1.44% | 114.25% | 8 440 |
| SYNEOS HEALTH, INC. | 1.63% | 1.14% | -30.94% | -18.18% | 70.83% | 7 157 |
| | | | | | | |
| | Durchschnitt | 1.03% | 1.30% | -24.52% | -10.91% | 114.60% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.06% | 0.58% | -28.16% | -12.29% | 163.12% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
